Common Contracts
1 similar Clinical Study Agreement contracts
CLINICAL STUDY AGREEMENT PROTOCOL: D5780C00007 SITE: 2003635XXXX INSTITUTION: KRAJSKA ZDRAVOTNI, A.S. MEDIMMUNE,LLC 17-MAY-2018VERSION: VERSION#1 COUNTRY: CZECH REPUBLIC SMLOUVA O KLINICKÉ STUDII PROTOKOL: D5780C00007 PRACOVIŠTĚ: 2003635 XXXX...Clinical Study Agreement • May 28th, 2018
CLINICAL STUDY AGREEMENTThis clinical study agreement (“Agreement”), is effective as of the day of publication of the fully executed Agreement in accordance with Clause 10.8 hereto (“Effective Date”), is entered into by and betweenMedpace Clinical Research, LLC, with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 ("Medpace”), represented by XXXX.; and Krajska zdravotni, a. s a with its principal office and place of business at Socialní pece 3316/12a, 401 13 Usti nad Labem, Czech Republic, ID 25488627, registred at evidence of County court of the Usti nad Labem ("Institution”), represented by XXXXCEO. Medpace and Institution are sometimes collectively referred to herein as parties (the “Parties”). WHEREAS, MEDIMMUNE, LLC (“Sponsor”) issponsoring a clinical study on the compound MEDI6012 (the “Study Drug”), in accordance with Protocol No. D5780C00007 titled “A Randomized, Placebo-controlled Phase 2b Study to Evaluate the Safety and Efficacy of MEDI
